Skip to the page

Data / Form D filings / EBS ACQ, LLC

EBS ACQ, LLC: Form D filing

EBS ACQ, LLC, a biotechnology company in Norwood, MA, filed a Form D with the SEC in 2024. The latest, on August 30, 2024, reports $1.8 million sold of a $1.8 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
29 ROYAL COURT, SUITE 100, Norwood, MA, 02062
Phone
(781) 352-5452
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2034656

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 30, 2024New notice$1,800,000$1,800,0007Feb 12, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Gerardus Jacobus HoetmerDirector
Brian Michael FoxDirector
Stephen GattoExecutive Officer, Director

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Aug 26, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what EBS ACQ, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.